Zhuhai Beihai Biotech Co., Ltd
5 clinical trials · Sponsor
◉ Watch Zhuhai Beihai Biotech Co., Ltd
| Record | Firm | Date |
|---|---|---|
| An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects (NCT06427681) | Zhuhai Beihai Biotech Co., Ltd | 2024-05-01 |
| A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer (NCT06232863) | Zhuhai Beihai Biotech Co., Ltd | 2023-01-18 |
| Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer (NCT06732531) | Zhuhai Beihai Biotech Co., Ltd | 2022-08-03 |
| Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors (NCT06231277) | Zhuhai Beihai Biotech Co., Ltd | 2022-04-26 |
| A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours (NCT04889599) | Zhuhai Beihai Biotech Co., Ltd | 2021-04-29 |
Track Zhuhai Beihai Biotech Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.